Core Scientific (NASDAQ:CORZ) reported quarterly sales of $95.400 million which missed the analyst consensus estimate of $102.425 million by 6.86 percent.
Core Scientific Q3 Sales $95.400M Miss $102.425M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.